Figure 5
Overall and event free survival of AML and MDS patients with blasts in the peripheral blood at time of HCT. AML/MDS patients: OS (A) and EFS (B) of the subgroup of patients with blasts in the peripheral blood at the time of HCT (n = 33).
Overall and event free survival of AML and MDS patients with blasts in the peripheral blood at time of HCT. AML/MDS patients: OS (A) and EFS (B) of the subgroup of patients with blasts in the peripheral blood at the time of HCT (n = 33).
